$1 - $2 ... lets worry about getting above 10c first.
management have a history of spending more than they make look at PAP, retractable needle - these were "company making" wastes of time and money really.
Lets focus on getting a run on the board with Artimist before worrying about nicosorb. the last annoucement merely indicated they were reviewing nicosorb - there is no indication as to when this is supposed to hit the markets and/or what further testing is required?
the coffee, page-42
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
